G-FINDER: tracking funding for global health R&D
Biomedical innovation — the development of new drugs, vaccines, diagnostics and other health technologies, and the fundamental basic research that makes this development possible — has been responsible for incredible gains in human health. But millions of people in the world still suffer needlessly because there is no commercial incentive to develop the products they need.
The G-FINDER project tracks annual investment in R&D for new products and technologies that are designed to address the persistent global health challenges that disproportionately affect the world's most disadvantaged people.
Our goal is to provide funders, policy makers, researchers, advocates, journalists and others with an accurate understanding of the R&D funding landscape for neglected diseases and other global health priorities. The G-FINDER data portal provides open access to all of the underlying data captured by the G-FINDER survey every year since 2007. Click on the 'Create your own visualisation' button or one of the quick filter buttons below to get started.
Use this button to share your data visualisations — including your filter selections and display options — with someone else. Results are also available for download.
Select a quick filter:
Sexual & reproductive health
Emerging infectious diseases
Total funding for ND R&D
Total funding for neglected tropical disease R&D (2018)
Increased investment in funding to PDPs for neglected diseases (2017-2018)
The G-FINDER project is conducted by Policy Cures Research, a not-for-profit global health think tank based in Sydney, and funded by the Bill & Melinda Gates Foundation.
We use the data collected through the G-FINDER project to produce a range of independent reports, which you can find here. This includes the annual G-FINDER neglected diseases reports:
Please include the following reference when citing or using text, figures, or data from this site:
Policy Cures Research, G-FINDER data portal, https://gfinderdata.policycuresresearch.org